(Q46646914)
Statements
1 reference
Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer (English)
1 reference
Roland Reitsamer
1 reference
Florentia Peintinger
1 reference
Eva Prokop
1 reference
Wolfgang Hitzl
1 reference
1 September 2005
1 reference
1 reference
16
1 reference
8
1 reference
867-870
1 reference